Organisation paid for research Program year 2021 Source: CMS Open Payments

Advanced RX Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$588,734

49 payments

Through program year 2021, Advanced RX Clinical Research is reported as receiving $588,734 in research payments, across 49 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$87,138	4
2020	Research	$209,587	11
2019	Research	$292,009	34

Breakdown

Who paid Research payments · program years 2019–2021

Incyte Corporation $355,633 39 payments
Romark Laboratories, LC $154,929 2 payments
Ironwood Pharmaceuticals, Inc $78,173 8 payments

Studies the money was for Research payments · program years 2019–2021

TRuE AD1-An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $218,552 7 payments
TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis $137,080 32 payments
A Phase III Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza $88,109 1 payment
McP-103-205 $75,513 6 payments
Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection $66,820 1 payment
McP-103-312 $2,660 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.